This is an oral medication in tablet form.
Aubagio® (teriflunomide), a pyrimidine synthesis inhibitor, is an oral compound that inhibits the function of specific immune cells that have been implicated in MS. It is related to leflunomide, a drug used to treat rheumatoid arthritis. Aubagio can inhibit a key enzyme required by white blood cells (lymphocytes) – which in turn reduces the proliferation of T and B immune cells that are active in MS and also inhibits the production of immune messenger chemicals by T cells.
Aubagio was approved by the U.S. Food and Drug Administration (FDA) in September, 2012 for patients with relapsing forms of multiple sclerosis.
Click here to see the FDA prescribing information for healthcare professionals.
Click here to see the FDA Medication Guide for patients.
MS One to One www.MSOnetoOne.com 1-855-MSOne2One (1-855-676-6326)
Financial Assistance Program
MS One to One www.MSOnetoOne.com